Missing link between microRNA and prostate cancer

Balraj Singh Gill1, Jimi Marin Alex2, Navgeet1

  • 1Centre for Biosciences, School of Basic and Applied Sciences, Central University of Punjab, Bathinda, 151001, India.

Insights

MicroRNAs (miRNAs) are key regulators of gene expression. Dysregulation of these molecules is linked to prostate cancer, highlighting their potential as therapeutic targets.

Area of Science:

  • Molecular Biology
  • Genetics
  • Oncology

Background:

  • MicroRNAs (miRNAs) are non-coding RNAs regulating gene expression in various organisms.
  • Aberrant miRNA levels, through genetic or epigenetic alterations, are implicated in disease pathogenesis, including cancer.
  • Emerging evidence points to a significant role for miRNAs in prostate cancer development and progression.

Purpose of the Study:

  • To review the current understanding of miRNA involvement in prostate cancer.
  • To explore the signaling pathways regulated by miRNAs in the context of prostate cancer.
  • To identify potential therapeutic molecular targets based on miRNA functions.

Main Methods:

  • Literature review of studies investigating miRNAs in prostate cancer.
  • Analysis of miRNA dysregulation mechanisms (deletions, overexpression, mutations, epigenetic silencing).
  • Examination of miRNA-controlled signaling pathways relevant to prostate cancer.

Main Results:

  • Numerous miRNA discoveries have advanced prostate cancer research, aiding in diagnosis and prediction.
  • While prediction has improved, effective treatment strategies for prostate cancer remain elusive.
  • miRNAs are involved in various cellular processes crucial to prostate cancer.

Conclusions:

  • miRNA dysregulation is a critical factor in prostate cancer.
  • Understanding miRNA-mediated signaling pathways is essential for identifying novel therapeutic targets.
  • Further research into miRNAs may unlock effective treatment strategies for prostate cancer.